How has been the historical performance of SMS Pharma.?
SMS Pharma has demonstrated significant growth in financial performance, with net sales increasing from 411.95 Cr in Mar'20 to 782.75 Cr in Mar'25, and a recovery in profit after tax from a loss of 7.06 Cr in Mar'23 to a profit of 67.40 Cr in Mar'25. Total assets and liabilities have also grown proportionally, indicating overall financial improvement.
Answer:The historical performance of SMS Pharma shows a fluctuating trend in key financial metrics over the years, with notable growth in recent periods.Breakdown:
SMS Pharma's net sales have increased from 411.95 Cr in Mar'20 to 782.75 Cr in Mar'25, indicating a strong upward trajectory. Total operating income followed a similar pattern, rising from 464.91 Cr in Mar'19 to 782.75 Cr in Mar'25. However, raw material costs have also escalated, reaching 501.87 Cr in Mar'25 from 259.50 Cr in Mar'20. The total expenditure, excluding depreciation, increased from 332.02 Cr in Mar'20 to 643.75 Cr in Mar'25. Operating profit, excluding other income, improved significantly from 54.48 Cr in Mar'23 to 139.00 Cr in Mar'25, while profit before tax rose from 5.35 Cr in Mar'23 to 92.34 Cr in Mar'25. The profit after tax showed a recovery, increasing from a loss of 7.06 Cr in Mar'23 to a profit of 67.40 Cr in Mar'25. The consolidated net profit also reflected this recovery, moving from a loss of 7.06 Cr in Mar'23 to a profit of 69.14 Cr in Mar'25. On the balance sheet, total assets grew from 558.81 Cr in Mar'19 to 1,034.09 Cr in Mar'24, while total liabilities increased from 558.81 Cr in Mar'19 to 1,034.09 Cr in Mar'24, indicating a proportional growth in both assets and liabilities. The cash flow from operating activities improved from 22.00 Cr in Mar'23 to 50.00 Cr in Mar'24, contributing to a net cash inflow of 28.00 Cr in Mar'24. Overall, SMS Pharma's financial performance has shown significant improvement in recent years, particularly in revenue and profitability.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
